Detalhe da pesquisa
1.
Feno differentiates epithelial gene expression clusters: Exploratory analysis from the MESOS randomized controlled trial.
J Allergy Clin Immunol;
150(4): 830-840, 2022 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35537502
2.
The VICM biomarker is released from activated macrophages and inhibited by anti-GM-CSFRα-mAb treatment in rheumatoid arthritis patients.
Clin Exp Rheumatol;
37(1): 73-80, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30418117
3.
Shared and Distinctive Transcriptomic and Proteomic Pathways in Adult and Juvenile Dermatomyositis.
Arthritis Rheumatol;
75(11): 2014-2026, 2023 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37229703
4.
Tumor Mutational Burden as a Predictor of Survival with Durvalumab and/or Tremelimumab Treatment in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
Clin Cancer Res;
29(11): 2066-2074, 2023 06 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36806911
5.
Serine/threonine phosphatase Stp1 mediates post-transcriptional regulation of hemolysin, autolysis, and virulence of group B Streptococcus.
J Biol Chem;
286(51): 44197-44210, 2011 Dec 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22081606
6.
Regulation of CovR expression in Group B Streptococcus impacts blood-brain barrier penetration.
Mol Microbiol;
77(2): 431-43, 2010 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20497331
7.
Resistance to Durvalumab and Durvalumab plus Tremelimumab Is Associated with Functional STK11 Mutations in Patients with Non-Small Cell Lung Cancer and Is Reversed by STAT3 Knockdown.
Cancer Discov;
11(11): 2828-2845, 2021 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34230008
8.
PD-L1+ neutrophils contribute to injury-induced infection susceptibility.
Sci Adv;
7(10)2021 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33674305
9.
Evaluation of ultra-low input RNA sequencing for the study of human T cell transcriptome.
Sci Rep;
9(1): 8445, 2019 06 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31186477
10.
A CD40L-targeting protein reduces autoantibodies and improves disease activity in patients with autoimmunity.
Sci Transl Med;
11(489)2019 04 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31019027
11.
Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus.
Lupus Sci Med;
5(1): e000261, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29644082
12.
Regulation of hemolysin expression and virulence of Staphylococcus aureus by a serine/threonine kinase and phosphatase.
PLoS One;
5(6): e11071, 2010 Jun 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20552019
13.
Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.
Arthritis Rheum;
60(6): 1785-96, 2009 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19479852
14.
Development of Potential Pharmacodynamic and Diagnostic Markers for Anti-IFN-α Monoclonal Antibody Trials in Systemic Lupus Erythematosus.
Hum Genomics Proteomics;
20092009 Nov 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20948567
15.
Type I interferon: potential therapeutic target for psoriasis?
PLoS One;
3(7): e2737, 2008 Jul 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18648529